PARIS, April 29, 2016 /PRNewswire/ — Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2016 Change Change (CER) Aggregate Group sales(1) €8,543m -1.9% +0.7% Business net income(2) €1,722m -0.2% +3.5% Business EPS(3) €1.34 +1.5% +5.3% Sanofi Chief Executive Officer, Olivier Brandicourt, commented: “I am pleased with the solid performance of the Group in the first quarter driven by […]